US HB8289 | 2021-2022 | 117th Congress
Status
Spectrum: Partisan Bill (Democrat 6-0)
Status: Introduced on July 5 2022 - 25% progression, died in committee
Action: 2022-07-05 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on July 5 2022 - 25% progression, died in committee
Action: 2022-07-05 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To require the Secretary of Health and Human Services to promulgate a past due final rule with respect to direct-to-consumer prescription drug advertisements, and for other purposes.
Title
Banning Misleading Drug Ads Act of 2022
Sponsors
Rep. Abigail Spanberger [D-VA] | Rep. Susan Wild [D-PA] | Rep. Katie Porter [D-CA] | Rep. Angela Craig [D-MN] |
Rep. Cindy Axne [D-IA] | Rep. Eleanor Norton [D-DC] |
History
Date | Chamber | Action |
---|---|---|
2022-07-05 | House | Referred to the House Committee on Energy and Commerce. |
2022-07-05 | House | Introduced in House |
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/117th-congress/house-bill/8289/all-info |
Text | https://www.congress.gov/117/bills/hr8289/BILLS-117hr8289ih.pdf |